Categories AlphaGraphs, Earnings, LATEST, Retail

PepsiCo tops Q3 revenue and earnings estimates; updates outlook

PepsiCo Inc. (PEP) beat market estimates on revenue and earnings for the third quarter of 2018. Despite the positive results, the stock is down slightly in premarket trade.

The food and beverages giant reported total revenues of $16.4 billion, up 1.5% from the same period last year. Organic revenue grew 4.9%.

Net income attributable to PepsiCo grew 16% to $2.4 billion, and diluted EPS rose 18% to $1.75 per share versus the prior-year period. Core EPS grew 7% to $1.59.

PepsiCo third quarter 2018 earnings results

PepsiCo saw revenue increases in the Frito-Lay North America and North America Beverages divisions while the Quaker Foods North America business saw a drop of 2%. The Frito-Lay snacks business continues to be the top revenue-generator for the company.

Revenues in Latin America remained flat. Revenues grew 2% in the Europe Sub-Saharan Africa division but fell 2% in the Asia, Middle East, and North Africa division.

Outlook

PepsiCo updated its guidance for the full year of 2018. The company now expects organic revenue growth to be at least 3%. Core EPS is expected to be $5.65, up 8% versus last year. Core constant currency EPS growth is touted to be 9%.

As customer preferences shift to healthier options, PepsiCo has been revamping its product line to cater to this trend. As part of these efforts, the company has made significant acquisitions such as Bare Foods and SodaStream. PepsiCo has also rolled out products like Bubly and KeVita which are doing well.

PepsiCo is also working to improve its online business as the prominence of e-commerce grows. Like its rival Coca-Cola, which acquired coffee chain Costa recently, Pepsi is diversifying into different products in order to maintain its solid footing and not rely too much on its signature cola brand.

Last month, PepsiCo chief Indra Nooyi announced her decision to step down as Chief Executive Officer after a tenure of 24 years with the company. Ramon Laguarta was appointed as her successor. This earnings call will be Ms. Nooyi’s last one as CEO with PepsiCo.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Comments

  1. Pingback: cam chat
  2. Pingback: lucabet
  3. Pingback: sagame

Comments are closed.

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top